Copyright Reports & Markets. All rights reserved.

Global Active Pharmaceutical Ingredients (API) Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Active Pharmaceutical Ingredients (API) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Active Pharmaceutical Ingredients (API) Consumption 2014-2024
        • 2.1.2 Active Pharmaceutical Ingredients (API) Consumption CAGR by Region
      • 2.2 Active Pharmaceutical Ingredients (API) Segment by Type
        • 2.2.1 Synthetic APIs
        • 2.2.2 Biotech APIs
      • 2.3 Active Pharmaceutical Ingredients (API) Consumption by Type
        • 2.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2014-2019)
      • 2.4 Active Pharmaceutical Ingredients (API) Segment by Application
        • 2.4.1 CNS
        • 2.4.2 Cardiovascular
        • 2.4.3 Genitourinary/Hormonal Drugs
        • 2.4.4 Respiratory
        • 2.4.5 Rheumatology
        • 2.4.6 Diabetes
        • 2.4.7 Oncology
        • 2.4.8 Others
      • 2.5 Active Pharmaceutical Ingredients (API) Consumption by Application
        • 2.5.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Active Pharmaceutical Ingredients (API) Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2014-2019)

      3 Global Active Pharmaceutical Ingredients (API) by Players

      • 3.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players
        • 3.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Players (2017-2019)
        • 3.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players (2017-2019)
      • 3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players
        • 3.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Players (2017-2019)
        • 3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players (2017-2019)
      • 3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Players
      • 3.4 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Active Pharmaceutical Ingredients (API) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Active Pharmaceutical Ingredients (API) by Regions

      • 4.1 Active Pharmaceutical Ingredients (API) by Regions
        • 4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
        • 4.1.2 Global Active Pharmaceutical Ingredients (API) Value by Regions
      • 4.2 Americas Active Pharmaceutical Ingredients (API) Consumption Growth
      • 4.3 APAC Active Pharmaceutical Ingredients (API) Consumption Growth
      • 4.4 Europe Active Pharmaceutical Ingredients (API) Consumption Growth
      • 4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Growth

      5 Americas

      • 5.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries
        • 5.1.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019)
        • 5.1.2 Americas Active Pharmaceutical Ingredients (API) Value by Countries (2014-2019)
      • 5.2 Americas Active Pharmaceutical Ingredients (API) Consumption by Type
      • 5.3 Americas Active Pharmaceutical Ingredients (API) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Countries
        • 6.1.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019)
        • 6.1.2 APAC Active Pharmaceutical Ingredients (API) Value by Countries (2014-2019)
      • 6.2 APAC Active Pharmaceutical Ingredients (API) Consumption by Type
      • 6.3 APAC Active Pharmaceutical Ingredients (API) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Active Pharmaceutical Ingredients (API) by Countries
        • 7.1.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019)
        • 7.1.2 Europe Active Pharmaceutical Ingredients (API) Value by Countries (2014-2019)
      • 7.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Type
      • 7.3 Europe Active Pharmaceutical Ingredients (API) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) by Countries
        • 8.1.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Type
      • 8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Active Pharmaceutical Ingredients (API) Distributors
      • 10.3 Active Pharmaceutical Ingredients (API) Customer

      11 Global Active Pharmaceutical Ingredients (API) Market Forecast

      • 11.1 Global Active Pharmaceutical Ingredients (API) Consumption Forecast (2019-2024)
      • 11.2 Global Active Pharmaceutical Ingredients (API) Forecast by Regions
        • 11.2.1 Global Active Pharmaceutical Ingredients (API) Forecast by Regions (2019-2024)
        • 11.2.2 Global Active Pharmaceutical Ingredients (API) Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Active Pharmaceutical Ingredients (API) Forecast by Type
      • 11.8 Global Active Pharmaceutical Ingredients (API) Forecast by Application

      12 Key Players Analysis

      • 12.1 Teva
        • 12.1.1 Company Details
        • 12.1.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Teva News
      • 12.2 Mylan
        • 12.2.1 Company Details
        • 12.2.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Mylan News
      • 12.3 DSM
        • 12.3.1 Company Details
        • 12.3.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 DSM News
      • 12.4 Aurobindo Pharma
        • 12.4.1 Company Details
        • 12.4.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Aurobindo Pharma News
      • 12.5 Aspen
        • 12.5.1 Company Details
        • 12.5.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Aspen News
      • 12.6 Novartis
        • 12.6.1 Company Details
        • 12.6.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Novartis News
      • 12.7 BASF
        • 12.7.1 Company Details
        • 12.7.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 BASF News
      • 12.8 Pfizer
        • 12.8.1 Company Details
        • 12.8.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Pfizer News
      • 12.9 Huahai Pharmaceutical
        • 12.9.1 Company Details
        • 12.9.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Huahai Pharmaceutical News
      • 12.10 Hisun Pharmaceutical
        • 12.10.1 Company Details
        • 12.10.2 Active Pharmaceutical Ingredients (API) Product Offered
        • 12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Hisun Pharmaceutical News
      • 12.11 Sun Pharmaceutical Industries
      • 12.12 Zhejiang Medicine
      • 12.13 Dr. Reddy’s Laboratories
      • 12.14 Zhejiang NHU
      • 12.15 Bayer
      • 12.16 NCPC
      • 12.17 AbbVie
      • 12.18 Shandong Xinhua Pharmaceutical
      • 12.19 Northeast Pharm
      • 12.20 Harbin Pharmaceutical
      • 12.21 LKPC

      13 Research Findings and Conclusion

      An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
      The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
      The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.
      Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.

      According to this study, over the next five years the Active Pharmaceutical Ingredients (API) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Active Pharmaceutical Ingredients (API) business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) market by product type, application, key manufacturers and key regions and countries.

      This study considers the Active Pharmaceutical Ingredients (API) value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Synthetic APIs
      Biotech APIs
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      CNS
      Cardiovascular
      Genitourinary/Hormonal Drugs
      Respiratory
      Rheumatology
      Diabetes
      Oncology
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Teva
      Mylan
      DSM
      Aurobindo Pharma
      Aspen
      Novartis
      BASF
      Pfizer
      Huahai Pharmaceutical
      Hisun Pharmaceutical
      Sun Pharmaceutical Industries
      Zhejiang Medicine
      Dr. Reddy’s Laboratories
      Zhejiang NHU
      Bayer
      NCPC
      AbbVie
      Shandong Xinhua Pharmaceutical
      Northeast Pharm
      Harbin Pharmaceutical
      LKPC

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Active Pharmaceutical Ingredients (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Active Pharmaceutical Ingredients (API) market by identifying its various subsegments.
      Focuses on the key global Active Pharmaceutical Ingredients (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Active Pharmaceutical Ingredients (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Active Pharmaceutical Ingredients (API) submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now